Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alnylam CEO John Maraganore: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)

Jul 06 2012

Related Content

Alnylam CEO John Maraganore: An Interview With "The Pink Sheet" DAILY (Part 2 of 2)

Mar 08 2011

Alnylam CEO John Maraganore - An Interview With "The Pink Sheet" DAILY (Part 1 of 2)

Mar 07 2011

European HTA Highlights: Discounts Soften NICE Approach But Germany’s IQWiG Shows Its Teeth

Apr 16 2012

Alnylam Announces 33% Staff Cut, Will Focus Internally On Two Lead RNAi Programs

Jan 20 2012

Roche Shakes Up R&D, Closes Nutley Operations

Jun 26 2012

Financings Of The Fortnight: Big FOPO For Troubled Alnylam, Plus First European IPO Of 2012 For Adocia

Feb 24 2012

Alnylam CEO John Maraganore – An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

Jul 05 2012

Roche Exits RNAi, Raising Questions For Stalwarts

Dec 01 2010

Related Companies

Alnylam Pharmaceuticals Inc.

Roche Holding AG

Novartis AG

Pfizer Inc.

Arrowhead Pharmaceuticals, Inc.

Additional Topics

United States Business Strategies Clinical Trials Innovation Platform Technologies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window